Details

Last Funding Type

Series D

Last Funding Money Raised

$39M

Industries

Biotechnology,Pharmaceutical,Therapeutics

Founded date

Jan 1, 2012

Number Of Employee

51 - 100

Operating Status

Active

Stock Symbol

nasdaq:RANI

Legal Name

Rani Therapeutics, Inc.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

They developed the RaniPill capsule, which is Rani's novel, proprietary, and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine.

To date, Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability, and bioavailability using the RaniPill capsule. Their development efforts have enabled them to construct an extensive intellectual property portfolio that they believe provides patients with a competitive advantage.